10x Genomics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 12 16:28 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
Mar 25 17:21 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 25 17:20 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
Mar 25 17:20 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 18 19:06 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 6 16:16 ET
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 18:42 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 26 16:18 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
Feb 26 16:17 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
Feb 26 16:16 ET
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 22 19:22 ET
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 22 19:07 ET
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 22 19:03 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 20 16:25 ET
10x Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 15 17:38 ET
10x Genomics | 10-K: Annual report
Feb 15 17:18 ET
10x Genomics | 8-K: 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
Feb 15 16:11 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 13 18:21 ET
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.65%)
Feb 13 18:17 ET
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(16.252%),Abigail P. Johnson(16.252%)
Feb 9 08:40 ET
No Data
No Data